CARTAS AL DIRECTORColitis ulcerosa, tacrolimus y curación mucosa
Bibliografía (9)
- et al.
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study
Gastroenterology
(2007) - et al.
Tacrolimus: a futher update of its pharmacology and therapeutic: use in the management of organ transplantation
Drugs
(2000) - et al.
The role of tacrolimus in inflammatory bowel disease: a systematic review
Dig Dis Sci
(2006) - et al.
A Randomised dose finding study of oral tacrolimus (FK 506) therapy in refractory ulcerative colitis
Gut
(2006)
There are more references available in the full text version of this article.
Cited by (1)
Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis
2022, Cochrane Database of Systematic Reviews
Copyright © 2008 Elsevier España, S.L. All rights reserved.